Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes
Clinical trial NCT00715663 · COMPLETED
Trial details
- NCT number
- NCT00715663
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-02-01
- Primary completion
- 2007-12-01
- Enrollment
- 1584
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.